Inventor · disambiguated record
Jacob P. Sizemore
Also filed as: SIZEMORE JACOB · SIZEMORE JACOB P · SIZEMORE JACOB PAUL
5 granted patents·2 pending applications·10 citations·filing 2014–2025
70Inventor score
Top patents by PatentIndex Score
7 records- 0187US11254652B2Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamideAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Feb 22, 2022·5 cites·8 claims
- 0284US9120795B2Crystalline form of a β-lactamase inhibitorCUBIST PHARM INC·Filed 2014·Granted Sep 1, 2015·5 cites·20 claims
- 0368US12297179B2Crystalline and salt forms of an organic compound and pharmaceutical compositions thereofSERVIER PHARMACEUTICALS LLC·Filed 2019·Granted May 13, 2025·0 cites·22 claims
- 0464US2025270175A1Crystalline and salt forms of an organic compound and pharmaceutical compositions thereofSERVIER PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 0562US12264148B2Ivosidenib forms and pharmaceutical compositionsSERVIER PHARMACEUTICALS LLC·Filed 2019·Granted Apr 1, 2025·0 cites·5 claims
- 0661US2022220093A1Crystalline forms of n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamideAGIOS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0752US12479824B2Method for preparing ivosidenib and an intermediate thereofSERVIER PHARMACEUTICALS LLC·Filed 2020·Granted Nov 25, 2025·0 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Jacob P. Sizemore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →